Ultragenyx (RARE) earnings · rev $673.0M
These earnings events as JSON? API free 100/dayUltragenyx (RARE) is a biotechnology company listed on US.
This RARE earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported RARE revenue for 2025-12-31 was $673.0M. Net income was -$575.0M. Revenue was up 20.1% from 2024-12-31 to 2025-12-31. RARE currently screens at market cap $2.79B.
When the next RARE 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 20.1% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full RARE research stays on the stock page; the tape stays on the quote page.
RARE earnings FAQ
What are RARE's latest revenue and net income?
Latest cached Ultragenyx (RARE) revenue for Dec 31, 2025 was $673.0M. Net income was -$575.0M. Statements: https://lician.com/financials/rare
What is RARE's latest diluted EPS?
Latest cached Ultragenyx (RARE) diluted EPS for Dec 31, 2025 was -$5.83.
What period does the latest RARE earnings print cover?
The latest cached Ultragenyx (RARE) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did RARE revenue change from the prior cached period?
Cached Ultragenyx (RARE) revenue was up 20.1% from $560.2M (Dec 31, 2024) to $673.0M (Dec 31, 2025). Statements: https://lician.com/financials/rare
Where are RARE earnings listed?
Cached earnings facts for Ultragenyx (RARE) are listed at https://lician.com/earnings/rare. Statements: https://lician.com/financials/rare
Not investment advice.